TXG · Insider Trading
10x Genomics, Inc. Class A Common Stock
Every open-market purchase and sale reported by TXG officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-24 | Serge Saxonov | Chief Executive Officer | Sell | −25,000 | −$2.03M |
| 2026-09-24 | Shehnaaz Suliman | Director | Sell | −5,723 | −$464.67K |
| 2026-09-11 | Adam Taich | Chief Financial Officer | Sell | −46,388 | −$3.00M |
| 2026-09-08 | John R Stuelpnagel | Director | Sell | −20,000 | −$1.24M |
| 2026-09-03 | Serge Saxonov | Chief Executive Officer | G | −100 | — |
| 2026-08-28 | Serge Saxonov | Chief Executive Officer | Sell | −10,486 | −$667.90K |
| 2026-08-26 | Benjamin J. Hindson | See Remarks | Sell | −13,818 | −$870.86K |
| 2026-08-26 | Serge Saxonov | Chief Executive Officer | Sell | −18,545 | −$1.17M |
| 2026-08-26 | Shehnaaz Suliman | Director | Sell | −2,207 | −$140.48K |
| 2026-08-26 | Adam Taich | Chief Financial Officer | Sell | −17,166 | −$1.08M |
| 2026-08-24 | Serge Saxonov | Chief Executive Officer | G | −4,000 | — |
| 2026-08-17 | Sarah A. Teichmann | Director | Sell | −7,551 | −$432.28K |
| 2026-08-13 | John R Stuelpnagel | Director | Sell | −20,000 | −$1.16M |
| 2026-06-24 | Serge Saxonov | Chief Executive Officer | Sell | −30,000 | −$1.03M |
| 2026-06-18 | Shehnaaz Suliman | Director | Sell | −5,723 | −$186.76K |
| 2026-06-08 | Shehnaaz Suliman | Director | A | +8,829 | — |
| 2026-06-08 | Alan Mateo | Director | A | +8,829 | — |
| 2026-06-08 | John R Stuelpnagel | Director | A | +8,829 | — |
| 2026-06-08 | Sarah A. Teichmann | Director | A | +8,829 | — |
| 2026-06-08 | Kimberly J Popovits | Director | A | +8,829 | — |
| 2026-06-08 | Sridhar Kosaraju | Director | A | +8,829 | — |
| 2026-05-27 | Benjamin J. Hindson | See Remarks | Sell | −11,595 | −$283.40K |
| 2026-05-27 | Adam Taich | Chief Financial Officer | Sell | −15,098 | −$369.02K |
| 2026-05-27 | Serge Saxonov | Chief Executive Officer | Sell | −28,893 | −$709.06K |
| 2026-04-16 | Serge Saxonov | Chief Executive Officer | Sell | −5,000 | −$122.78K |
| 2026-03-25 | Serge Saxonov | Chief Executive Officer | Sell | −15,000 | −$288.91K |
| 2026-03-04 | Serge Saxonov | Chief Executive Officer | MIXED | −18,902 | −$367.10K |
| 2026-03-02 | Benjamin J. Hindson | See Remarks | A | +88,816 | — |
| 2026-03-02 | Serge Saxonov | Chief Executive Officer | A | +157,895 | — |
| 2026-03-02 | Adam Taich | Chief Financial Officer | A | +106,579 | — |
| 2026-02-27 | Sarah A. Teichmann | Director | Sell | −7,579 | −$147.11K |
| 2026-02-25 | Benjamin J. Hindson | See Remarks | Sell | −7,826 | −$145.38K |
| 2026-02-25 | Serge Saxonov | Chief Executive Officer | Sell | −9,632 | −$178.93K |
| 2026-02-25 | Adam Taich | Chief Financial Officer | Sell | −8,968 | −$166.59K |
| 2026-01-07 | Serge Saxonov | Chief Executive Officer | M | +50,000 | +$60.00K |
| 2025-11-25 | Serge Saxonov | Chief Executive Officer | Sell | −13,261 | −$251.94K |
| 2025-11-25 | Adam Taich | Chief Financial Officer | Sell | −11,888 | −$225.85K |
| 2025-11-25 | Benjamin J. Hindson | See Remarks | Sell | −8,283 | −$157.36K |
| 2025-09-16 | Serge Saxonov | Chief Executive Officer | G | −900 | — |
| 2025-08-26 | Benjamin J. Hindson | See Remarks | Sell | −7,486 | −$103.21K |
| 2025-08-26 | Serge Saxonov | Chief Executive Officer | Sell | −9,348 | −$128.88K |
| 2025-08-26 | Adam Taich | Chief Financial Officer | Sell | −22,315 | −$307.66K |
| 2025-06-11 | Serge Saxonov | Chief Executive Officer | G | −1,000 | — |
| 2025-06-05 | Shehnaaz Suliman | Director | A | +15,357 | — |
| 2025-06-05 | John R Stuelpnagel | Director | A | +15,357 | — |
| 2025-06-05 | Alan Mateo | Director | A | +15,357 | — |
| 2025-06-05 | Sarah A. Teichmann | Director | A | +15,357 | — |
| 2025-06-05 | Sridhar Kosaraju | Director | A | +15,357 | — |
| 2025-06-05 | Kimberly J Popovits | Director | A | +15,357 | — |
| 2025-06-02 | Serge Saxonov | Chief Executive Officer | G | −3,000 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Serge Saxonov | Chief Executive Officer | 1,062,976 | $74.29M |
| Benjamin J. Hindson | See Remarks | 488,182 | $34.12M |
| Adam Taich | Chief Financial Officer | 361,526 | $25.27M |
| John R Stuelpnagel | Director | 341,424 | $23.86M |
| Alan Mateo | Director | 85,877 | $6.00M |
| Sridhar Kosaraju | Director | 68,278 | $4.77M |
| Kimberly J Popovits | Director | 37,445 | $2.62M |
| Sarah A. Teichmann | Director | 30,331 | $2.12M |
| Shehnaaz Suliman | Director | 23,792 | $1.66M |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the TXG quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.